CCL4 signaling promotes tumorigenesis, invasion, and recurrence by recruiting macrophages and influencing the tumor microenvironment 60, while CCL5 promotes tumor growth, metastasis, angiogenesis (new blood vessel formation), drug resistance, and the self-renewal of cancer stem cells through its receptor CCR5 60. The gene discussed is CCL5; the disease is neoplasm.